Barbara J. Rowland

Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.

Alexander J. Makowski, J. Nyman, B. Nayak, 2016, Bone.

Assessment of Breast Cancer Induced Bone Quality Changes Using Raman Spectroscopy

J. Nyman, A. Mahadevan-Jansen, X. Bi, 2012 .

The loss of activating transcription factor 4 (ATF4) reduces bone toughness and fracture toughness.

Alexander J. Makowski, J. Nyman, A. Mahadevan-Jansen, 2014, Bone.

Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis.

Alexander J Makowski, Sasidhar Uppuganti, Jeffry S Nyman, 2015, BoneKEy reports.